Nanospectra Biosciences
PrivateLast Round
Series B
Extension
Sep 8, 2020
Est. Valuation
$25M
Total Funding Raised
$7.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanospectra Biosciences is a medical device company developing nanoparticle-based therapies for the thermal ablation of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanospectra Biosciences Comparables
Compare Nanospectra Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sona Nanotech | 83% | |
| Brodie Generational Capital Partners | 78% | |
| Clinical Laserthermia Systems | 77% |
Nanospectra Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 8, 2020 | ||||
| Angel | Jun 4, 2013 | ||||
| Grant | Sep 30, 2012 | ||||
| Grant | Sep 30, 2011 | ||||
| Debt | Nov 16, 2010 | ||||
Series A | Jan 1, 2009 |
Nanospectra Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Houston Angel Network | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 660% MoM.
- Jan 20, 2026
Monthly visitors increased 45% MoM, reaching 1.2K.
Nanospectra Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanospectra Biosciences's valuation, stock price, and market status.
Is Nanospectra Biosciences a public or private company?
Nanospectra Biosciences is a private company.
What is the current stock price of Nanospectra Biosciences?
Nanospectra Biosciences is a private company, so its shares have no public market price. Caplight tracks Nanospectra Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanospectra Biosciences worth (valuation)?
Nanospectra Biosciences's valuation is estimated at $25.0M based on funding round data.
Can I buy Nanospectra Biosciences stock?
Nanospectra Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanospectra Biosciences's last funding round?
Nanospectra Biosciences's most recent funding round was Series B Extension on September 8, 2020.
Who are the main investors in Nanospectra Biosciences?
Key investors in Nanospectra Biosciences include NIH RADx.
Will Nanospectra Biosciences IPO soon?
No public IPO plans have been announced for Nanospectra Biosciences.
How can I track Nanospectra Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Nanospectra Biosciences's shares on secondary markets.